InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

SomnoMed Limited (ASX: SOM) - Announcements

Current share price for SOM : $0.460 0.02 (4.17%)+

ASX company news and announcements for SomnoMed Limited (SOM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SomnoMed Limited (SOM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SomnoMed Limited (SOM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SomnoMed Limited (SOM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$101 Appendix 4C - quarterly 26 Oct 2009 9:51AM $0.039 $0.460 risen by 1,079.49%
$101 Somnomed now profitable 26 Oct 2009 9:50AM $0.039 $0.460 risen by 1,079.49%
$101 SomnoMed to market SMH BFlex material in Japan 20 Oct 2009 10:08AM $0.033 $0.460 risen by 1,293.94%
$101 Preliminary Final Report 27 Aug 2009 10:16AM $0.027 $0.460 risen by 1,603.70%
$101 Appendix 4C - quarterly 31 Jul 2009 2:44PM $0.022 $0.460 risen by 1,990.91%
$101 Appendix 4C - quarterly 27 Apr 2009 8:31AM $0.026 $0.460 risen by 1,669.23%
$101 Half Yearly Report and Accounts 24 Feb 2009 2:06PM $0.018 $0.460 risen by 2,455.56%
$101 Somnomed enters Japan 16 Feb 2009 2:37PM $0.019 $0.460 risen by 2,321.05%
$101 Appendix 4C - Quarterly Cashflow Report 29 Jan 2009 4:03PM $0.020 $0.460 risen by 2,200%
$101 SomnoMed Granted European Patent Registration 7 Nov 2008 11:53AM $0.019 $0.460 risen by 2,321.05%
$101 Somnomed growth continues unabated 27 Oct 2008 10:44AM $0.021 $0.460 risen by 2,090.48%
$101 Quarterly Cashflow Report 27 Oct 2008 10:39AM $0.017 $0.460 risen by 2,605.88%
$101 Preliminary Final Report 28 Aug 2008 4:09PM $0.025 $0.460 risen by 1,740%
$101 USA Subsidiary achieves fourth quarter profitability 28 Jul 2008 9:25AM $0.030 $0.460 risen by 1,433.33%
$101 Appendix 4C - quarterly 28 Jul 2008 9:21AM $0.030 $0.460 risen by 1,433.33%
$101 UK Distribution Partner appointed - Intus Healthcare 8 Jul 2008 10:09AM $0.034 $0.460 risen by 1,252.94%
$101 Response to ASX Price Query 10 Jun 2008 10:02AM $0.029 $0.460 risen by 1,486.21%
$101 Price Query Letter 10 Jun 2008 10:01AM $0.029 $0.460 risen by 1,486.21%
$101 Appendix 4C - quarterly 30 Apr 2008 8:53AM $0.016 $0.460 risen by 2,775%
$101 Europeon Distribution Partner appointments 19 Mar 2008 12:56PM $0.016 $0.460 risen by 2,775%
$101 Half Yearly Report and Accounts 25 Feb 2008 3:42PM n/a $0.460 n/a
$101 Appendix 4C - quarterly 31 Jan 2008 1:25PM $0.016 $0.460 risen by 2,775%
$101 FDA Approval SMH BFlex Biomaterial 30 Jan 2008 12:01PM $0.016 $0.460 risen by 2,775%
$101 Somnomed signs License Agreement in USA 18 Dec 2007 4:09PM $0.022 $0.460 risen by 1,990.91%
$101 Appendix 4C - quarterly 31 Oct 2007 4:23PM $0.025 $0.460 risen by 1,740%

626 - 650 of 675 results

Page 26 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.